The involvement of lysosomes in myocardial aging and disease

Current Cardiology Reviews

Volumn 4, Issue 2, 2008, Pages 107-115

  Terman, Alexei ^a,b   Kurz, Tino ^a   Gustafsson, Bertil ^c   Brunk, Ulf T ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aging; Apoptosis; Autophagy; Cardiac myocytes; Mitochondria; Oxidative stress

Indexed keywords

CALPAIN; DEFERIPRONE; FERRITIN; IRON CHELATING AGENT; LIPOFUSCIN; LYSOSOME ENZYME; MITOCHONDRIAL DNA; PROTEINASE; REACTIVE OXYGEN METABOLITE; SALICYLALDEHYDE ISONICOTINOYLHYDRAZONE;

AGING; APOPTOSIS; AUTOPHAGY; CARDIOMYOPATHY; CELL SURVIVAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART FAILURE; HEART MITOCHONDRION; HEART MUSCLE NECROSIS; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; LYSOSOME; LYSOSOME MEMBRANE; LYSOSOME STORAGE DISEASE; MITOCHONDRIAL MEMBRANE POTENTIAL; MYOCARDIAL DISEASE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; SENESCENCE;

EID: 41049090468     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340308784245801     Document Type: Review

References (109)

1. Grote J. In Schmidt RF, Thews G Eds. Human Physiology. Berlin, Springer-Verlag 1989; 598-613.
2. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM. Myocyte cell loss and myocyte cellular hypeplasia in the hypertrophied aging rat heart. Circ Res 1990; 67: 871-85.
3. Terman A, Gustafsson B, Brunk UT. Autophagy, organelles and ageing. J Pathol 2007; 211: 134-43.
4. Terman A, Brunk UT. Is aging the price for memory? Biogerontology 2005; 6: 205-10.
5. Kunapuli S, Rosanio S, Schwarz ER. "How do cardiomyocytes die"? apoptosis and autophagic cell death in cardiac myocytes. J Card Fail 2006; 12: 381-91.
6. Hamacher-Brady A, Brady NR, Gottlieb PA. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 2006; 20: 445-62.
7. Sohal RS. Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med 2002; 33: 37-44.
8. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A 1994; 91: 10771-8.
9. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 211: 298-300.
10. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000; 29: 222-30.
11. Barja G. Rate of generation of oxidative stress-related damage and animal longevity. Free Radic Biol Med 2002; 33: 1167-72.
12. Zhang M, Rosen JM. Stem. cells in the etiology and treatment of cancer. Curr Opin Genet Dev 2006; 16: 60-4.
13. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-21.
14. Cuervo AM. Autophagy: many paths to the same end. Mol Cell Biochem 2004; 263: 55-72.
15. Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 2005; 1: 131-40.
16. Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ 2005; 12 Suppl 2: 1542-52.
17. Klionsky DJ, Cregg JM, Dunn WA, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003; 5: 539-45.
18. Takagi H, Matsui Y, Sadoshima J. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid Redox Signal 2007; 9: 1373-81.
19. Nakai A, Yamaguchi O, Takeda, T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007; 13: 619-24.
20. Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 2005; 68: 355-65.
21. Terman A, Dalen H, Brunk UT. Ceroid/lipofuscin-loaded human fibroblasts show decreased survival time and diminished autophagocytosis during amino acid starvation. Exp Gerontol 1999; 34: 943-57.
22. Seglen PO, Gordon PB, 3-Methyladenine: specific inhibitor of autophagic/ lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 1982; 79: 1889-92.
23. Ohshita T, Kominami E, Ii K, Katunuma N. Effect of starvation and refeeding on autophagy and heterophagy in rat liver. J Biochem (Tokyo) 1986; 100: 623-32.
24. de Waal EJ, Vreeling-Sindelarova H, Schellens JP, James J. Starvation-induced microautophagic vacuoles in rat myocardial cells. Cell Biol Int Rep 1986; 10: 527-33.
25. Wohlgemuth SE, Julian D, Akin DE, et al. Autophagy in the Heart and Liver During Normal Aging and Calorie Restriction. Rejuvenation Res 2007.
26. Decker RS, Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. I Ultrastructural and cytochemical changes. Am J Pathol 1980; 98: 425-44.
27. Yan L, Vatner DE, Kim SJ, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A 2005; 102: 13807-12.
28. Yan L, Sadoshima J, Vatner DE, Vatner SF. Autophagy: a novel protective mechanism in chronic ischemia. Cell Cycle 2006; 5: 1175-7.
29. Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin l in mediating autophagy. Circ Res 2007; 100: 914-22.
30. Valentim L, Laurence KM, Townsend PA, et al. Urocortin inhibits Beclinl-mediated autophagic cell death in cardiac myocytes exposed to iscbacmia/reperfusion injury. J Mol Cell Cardiol 2006; 40: 846-52.
31. Fengsrud M, Sneve ML, Overbye A, Seglen PO. In: Klionsky DJ Ed, Autophagy. Georgetown, TX, Landes Bioscience 2004; 11-25.
32. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 2004; 36: 2503-18.
33. Noda T, Suzuki K, Ohsumi Y. Yeast autophagosomes: de novo formation of a membrane structure. Trends Cell Biol 2002; 12: 231-5.
34. Dice JF. Peptide, sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 1990; 15: 305-9.
35. Cuervo AM, Dice JF. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996; 273: 501-3.
36. Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 2006; 73: 205-35.
37. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 2001; 8: 569-81.
38. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16: 663-9.
39. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306: 990-5.
40. Mitra AK, Dhume AS, Agrawal DK. "Vulnerable plaques"--ticking of the time bomb. Can J Physiol Pharmacol 2004; 82: 860-71.
41. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32-43.
42. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007; 8: 405-13.
43. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
44. Brunk UT, Neuzil J, Eaton JW. Lysosomal involvement in apoptosis. Redox Rep 2001; 6: 91-7.
45. Terman A, Kurz T, Gustafsson B, Brunk UT. Lysosomal labilization. IUBMB Life 2006; 58: 531-9.
46. Cirman T, Oresic K, Mazovec GD, et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated-by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004; 279: 3578-87.
47. Feldstein AE, Werneburg NW, Li Z, Bronk SF, Gores GJ. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1339-46.
48. Li W, Yuan X, Nordgren G, et al. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 2000; 470: 35-9.
49. Kågedal K, Zhao M, Svensson I, Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 2001; 359: 335-43.
50. 2 is a consequence of lysosomal rupture. Biochem J 2001; 356: 549-55.
51. Miyawaki H. Histochemistry and Electron Microscopy of Iron-Containing Granules, Lysosomes, and Lipofuscin in Mouse Mammary Glands. J Natl Cancer Inst 1965; 34: 601-23.
52. Brun A, Brunk U. Histochemical indications for lysosomal localization of heavy metals in normal rat brain and liver. J Histochem Cytochem 1970; 18: 820-7.
53. Schraufstätter I, Hyslop PA, Jackson JH, Cochrane CG. Oxidant-induced DNA damage of target cells. J Clin Invest 1988; 82: 1040-50.
54. Sakaida I, Kyle ME, Farber JL. Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress. Mol Pharmacol 1990; 37: 435-42.
55. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-77.
56. Baird SK, Kurz T, Brunk UT. Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem J 2006; 394: 275-83.
57. Nilsson E, Ghassemifar R, Brunk UT. Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress. Histochem J 1997; 29: 857-65.
58. Tenopoulou M, Doulias PT, Barbouti A, Brunk U, Galaris D. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem J 2005; 387: 703-10.
59. Zdolsek JM, Roberg K, Brunk UT. Visualization of iron in cultured macrophages: a cytochemical light and electron microscopic study using autometallography. Free Radic Biol Med 1993; 15: 1-11.
60. Yu Z, Persson HL, Eaton JW, Brunk UT. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic Biol Med 2003; 34: 1243-52.
61. Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004; 200: 425-35.
62. Janssen AM, van Duijn W, Kubben FJ, et al. Prognostic significance of metallothionein in human gastrointestinal cancer. Clin Cancer Res 2002; 8: 1889-96.
63. Joseph MG, Banerjee D, Kocha W, Feld R, Stitt LW, Cherian MG. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome. Cancer 2001; 92: 836-42.
64. Kakolyris S, Giatromanolaki A, Koukourakis M, et al. Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer., Clin Cancer Res 2001; 7: 3087-91.
65. Kurz T, Terman A, Brunk UT. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch Biochem Biophys 2007; 462: 220-30.
66. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-39.
67. Miyata S, Takemura G, Kawase Y, et al. Autophagic cardiomyo- cyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol 2006; 168: 386-97.
68. Knaapen MW, Davies MJ, De Bie M, Haven AJ, Martinet W, Kockx MM. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 2001; 51: 304-12.
69. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107: 984-91.
70. Kostin S, Pool L, Elsasser A, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 2003; 92: 715-24.
71. Terman A, Brunk UT. Lipofuscin. Int J Biochem Cell Biol 2004; 36: 1400-4.
72. Nakano M, Oenzil F, Mizuno T, Gotoh S. Age-related changes in the lipofuscin accumulation of brain and heart. Gerontology 1995; 41 Suppl 2: 69-79.
73. Brunk UT, Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 2002; 33: 611-9.
74. Collins VP, Arborgh B, Brunk U, Schellens JP. Phagocytosis and degradation of rat liver mitochondria by cultivated human glial cells. Lab Invest 1980; 42: 209-16.
75. Terman A, Gustafsson B, Brunk UT. Mitochondrial damage and intralysosomal degradation in cellular aging. Mol Aspects Med 2006; 27: 471-82.
76. Brunk U. Distribution and shifts of ingested marker particles in residual bodies and other lysosomes. Studies on in vitro cultivated human glia cells in phase II and 3. Exp Cell Res 1973; 79: 15-27.
77. Terman A, Brunk UT. Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis. Mech Ageing Dev 1998; 104: 277-91.
78. Terman A, Brunk UT. On the degradability and exocytosis of ceroid/ lipofuscin in cultured rat cardiac myocytes. Mech Ageing Dev 1998; 100: 145-56.
79. de Grey AD. A proposed refinement of the mitochondrial free radical tbeory of aging. Bioessays 1997; 19: 161-6.
80. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Mitochondrial recycling and aging of cardiac myocres: the role of autophagocytosis. Exp Gerontol 2003; 38: 863-76.
81. Sachs HG, Colgan JA, Lazarus ML. Ultrastructure of the aging myocardium: a morphometric approach. Am J Anat 1977; 150: 63-71.
82. Brunk U, Ericsson JL. Electron microscopical studies on rat brain neurons. Localization of acid phosphatase and mode of formation of lipofuscin bodies. J Ultrastruct Res 1972; 38: 1-15.
83. Terman A. Garbage catastrophe theory of aging: imperfect removal of oxidative damage? Redox Rep 2001; 6: 15-26.
84. Terman A, Brunk UT. Oxidative stress, accumulation of biological 'garbage', and aging. Antioxid Redox Signal 2006; 8: 197-204.
85. Stroikin Y, Dalen H, Loof S, Terman A. Inhibition of autophagy with 3-methyladenine results in impaired turnover of lysosomes and accumulation of lipofuscin-like material. Eur J Cell Biol 2004; 83: 583-90.
86. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann N Y Acad Sci 2004; 1019: 70-7.
87. Martinez-Vicente M, Cuervo AM. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 2007; 6: 352-61.
88. Bergamini E, Cavallini G, Donati A, Gori Z. The role of macroautophagy in the ageing process, anti-ageing intervention and age-associated diseases. Int J Biochem Cell Biol 2004; 36: 2392-404.
89. Terman A. The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocytes. Gerontology 1995; 41 (Suppl 2): 319-26.
90. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002; 269: 1996-2002.
91. Terman A, Gustafsson B, Brunk UT. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact 2006; 163: 29-37.
92. Stroikin Y, Johansson U, Asplund S, Ollinger K. Increased resistance of lipofuscin-loaded prematurely senescent fibroblasts to starvation-induced programmed cell death. Biogerontology 2007; 8: 43-53.
93. Brunk UT. Growing cells at 40% ambient oxygen conditions them to subsequent oxidative stress. Biogerontology 2007; 8: 619-20.
94. Terman A, Abrahamsson N, Brunk UT. Ceroid/lipofuscin-loaded human fibroblasts show increased susceptibility to oxidative stress. Exp Gerontol 1999; 34: 755-70.
95. Codd MB, Sugrue DD, Gersh BJ, Melton LJ, 3rd. Epidemiology of idiopathic dilated and hypertropbic cardiomyopathy, A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989; 80: 564-72.
96. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev 2000; 5: 167-73.
97. Uchino M, Uyama E, Kawano, H, et al. A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier. Acta Neuropathol (Berl) 1995; 90: 334-8.
98. Tanaka Y, Guhde G, Suter A, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000; 406: 902-6.
99. Raben N, Fukuda T, Gilbert AL, et al. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol Ther 2005; 11: 48-56.
100. Verity MA. Infantile Pompe's disease, lipid storage, and partial carnitine deficiency. Muscle Nerve 1991; 14: 435-40.
101. Yu W, Gong JS, Ko M, Garver WS, Yanagisawa K, Michikawa M. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J Biol Chem 2005; 280: 11731-9.
102. Marin-Garcia J, Goldenthal MJ, Moe GW. Mitochondrial pathology in cardiac failure. Cardiovasc Res 2001; 49: 17-26.
103. Tanguy S, de Leiris J, Besse S, Boucher F. Ageing exacerbates the cardiotoxicity of hydrogen peroxide through the Fenton reaction in rats. Mech Ageing Dev 2003; 124: 229-35.
104. Kurz T, Leake A, Von Zglinicki T, Brunk UT. Relocalized redoxactive lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Biochem J 2004; 378: 1039-45.
105. Kurz T, Gustafsson B, Brunk UT. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage. FEBS J 2006; 273: 3106-17.
106. Vitolo LMW, Hefter GT, Clare BW, Webb J. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Part II. Formation-constants with iron(III) and iron(II). Inorg Chim Acta 1990; 170: 171-6.
107. Simunek T, Boer C, Bouwman RA, et al. SIH-a novel lipophilic iron chelator-protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. J Mol Cell Cardiol 2005; 39: 345-54.
108. Kontoghiorghes GJ, Aldouri MA, Sheppard L, Hoffbrand AV. 1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Lancet 1987; 1: 1294-5.
109. Liu ZD, Liu DY, Hider RC. Iron chelator chemistry. Adv Exp Med Biol 2002; 509: 141-66.